Search results for "Enzyme binding"

showing 4 items of 4 documents

Spontaneous domain formation of phospholipase A2 at interfaces: fluorescence microscopy of the interaction of phospholipase A2 with mixed monolayers …

1992

Abstract Fluorescence microscopy has recently been proven to be an ideal tool to investigated the specific interaction of phospholipase A 2 with oriented substrate monolayers. Using a dual labeling technique, it could be shown that phospholipase A 2 can specifically attack and hydrolyze solid analogous l -α-DPPC domains. After a critical extent of monolayer hydrolysis the enzyme itself starts to aggregate forming regular shaped protein domains (Grainger et al. (1990) Biochim. Biophys. Acta 1023. 365–379). In order to confirm that the existence of hydrolysis products in the mononlayer is necessary for the observed aggregation of phospholipase A 2 , mixed monolayers of d - and l -α-DPPC, l -α…

12-DipalmitoylphosphatidylcholineCarboxylic acidProtein domainBiophysicsPhospholipidBiochemistryPhospholipases Achemistry.chemical_compoundPhospholipase A2MonolayerOrganic chemistryColoring Agentschemistry.chemical_classificationElapid VenomsPhospholipase AbiologyRhodaminesHydrolysisFatty AcidsSubstrate (chemistry)LysophosphatidylcholinesCell BiologyFluoresceinsEnzyme bindingPhospholipases A2chemistryMicroscopy Fluorescencebiology.proteinBiophysicsPhosphatidylcholinesFluoresceinDecanoic AcidsBiochimica et biophysica acta
researchProduct

Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase

2016

Heparanase is a β-d-glucuronidase which cleaves heparan sulfate chains in the extracellular matrix and on cellular membranes. A dysregulated heparanase activity is intimately associated with cell invasion, tumor metastasis and angiogenesis, making heparanase an attractive target for the development of anticancer therapies. SST0001 (roneparstat; Sigma-Tau Research Switzerland S.A.) is a non-anticoagulant 100% N-acetylated and glycol-split heparin acting as a potent heparanase inhibitor, currently in phase I in advanced multiple myeloma. Herein, the kinetics of heparanase inhibition by roneparstat is reported. The analysis of dose-inhibition curves confirmed the high potency of roneparstat (I…

Protein Conformation alpha-Helical0301 basic medicineSST0001Molecular modelhomology modelingAmino Acid MotifsPlasma protein bindingMolecular Dynamics SimulationBiochemistryMolecular Docking SimulationheparanaseSubstrate Specificity03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePolysaccharidesHumansProtein Interaction Domains and MotifsHeparanaseHomology modelingEnzyme InhibitorsGlucuronidaseBinding Siteskinetic inhibition analysisHeparinComputational BiologyHeparan sulfateRecombinant ProteinsAcidobacteriaMolecular Docking SimulationEnzyme bindingKinetics030104 developmental biologyCarbohydrate SequenceFondaparinuxchemistryBiochemistryStructural Homology ProteinDocking (molecular)030220 oncology & carcinogenesisBiophysicsroneparstatThermodynamicsProtein Conformation beta-StrandORIGINAL ARTICLESProtein BindingGlycobiology
researchProduct

Alkylation at the active site of the D-3-hydroxybutyrate dehydrogenase (BDH), a membrane phospholipid-dependent enzyme, by 3-chloroacetyl pyridine ad…

1997

The structure of the rat liver's D-3-hydroxybutyrate dehydrogenase (BDH) active site has been investigated using an affinity alkylating reagent, the 3-chloroacetyl pyridine adenine dinucleotide (3-CAPAD). This NAD+ analogue reagent strongly inactivates the enzyme following a concentration- and time-dependent process with a stoichiometry of approximately 1. The reagent reacts at the coenzyme binding site as revealed by the efficient protection by NADH. The effect of 3-CAPAD is stronger with the enzyme into its natural membrane environment than with the lipid-free purified apoBDH or with the reconstituted apoBDH-mitochondrial phospholipid complex. The pH-dependent effect on the inactivation p…

AlkylationStereochemistryAffinity labelMitochondria LiverDehydrogenaseBiochemistryHydroxybutyrate DehydrogenaseMembrane LipidsAnimalsCoenzyme bindingCysteineBinding sitePhospholipidsBinding SitesAffinity labelingMolecular StructurebiologyChemistryActive siteAffinity LabelsGeneral MedicineNADRatsReagentLinear Modelsbiology.proteinNAD+ kinaseBiochimie
researchProduct

Development of enzymatically-active bacterial cellulose membranes through stable immobilization of an engineered beta-galactosidase

2018

Enzymatically-active bacterial cellulose (BC) was prepared by non-covalent immobilization of a hybrid enzyme composed by a β-galactosidase from Thermotoga maritima (TmLac) and a carbohydrate binding module (CBM2) from Pyrococcus furiosus. TmLac-CBM2 protein was bound to BC, with higher affinity at pH 6.5 than at pH 8.5 and with high specificity compared to the non-engineered enzyme. Both hydrated (HBC) and freeze-dried (DBC) bacterial cellulose showed equivalent enzyme binding efficiencies. Initial reaction rate of HBC-bound enzyme was higher than DBC-bound and both of them were lower than the free enzyme. However, enzyme performance was similar in all three cases for the hydrolysis of 5% l…

0301 basic medicineImmobilized enzyme02 engineering and technologyProtein EngineeringBiochemistryBacterial cellulose03 medical and health sciencesHydrolysischemistry.chemical_compoundCarbohydrate binding moduleStructural BiologyEnzyme StabilityThermotoga maritimaCelluloseMolecular BiologyLactasechemistry.chemical_classificationbiologyGluconacetobacter xylinusHydrolysisMembranes ArtificialGeneral Medicine021001 nanoscience & nanotechnologybiology.organism_classificationEnzymes Immobilizedbeta-GalactosidaseEnzyme binding030104 developmental biologyEnzymeProtein immobilizationchemistryBiochemistryBacterial celluloseThermotoga maritimaPyrococcus furiosusCarbohydrate-binding module0210 nano-technology
researchProduct